(Q74170641)

English

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lympho

scientific article published on 01 June 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Groupe d'Etudes des Lymphomes de l'Adulte (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Caroline Besson

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

E Lepage

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

C Thieblemont

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

D Simon

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

C Rose

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

H Tilly

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Sonet

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P Lederlin

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Attal

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

J Brière

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

F Reyes

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 June 2000

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

685-690

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008394827806

7 January 2021

based on heuristic

inferred from DOI database lookup

Central nervous system complications of non-Hodgkin's lymphoma. The potential role for prophylactic therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008394827806

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of the central nervous system in non-hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008394827806

7 January 2021

based on heuristic

inferred from DOI database lookup

Central Nervous System Involvement in Patients with Diffuse Aggressive Non-Hodgkinʼs Lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008394827806

7 January 2021

based on heuristic

inferred from DOI database lookup

Central nervous system involvement in non-Hodgkin's lymphoma: an analysis of 105 cases

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008394827806

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary central nervous system involvement by non-Hodgkin's lymphoma: the risk factors.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008394827806

7 January 2021

based on heuristic

inferred from DOI database lookup

Central nervous system relapse in non-Hodgkin lymphoma. A single-center study of 532 patients.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008394827806

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated central nervous system relapse in aggressive non-Hodgkin's lymphoma: the Bologna experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008394827806

7 January 2021

based on heuristic

inferred from DOI database lookup

LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008394827806

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008394827806

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008394827806

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy of Burkitt and other B-cell acute lymphoblastic leukaemia and lymphoma: experience with the LMB protocols of the SFOP (French Paediatric Oncology Society) in children and adults

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008394827806

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008394827806

7 January 2021

based on heuristic

inferred from DOI database lookup

Testicular lymphoma: late relapses and poor outcome despite doxorubicin-based therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008394827806

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1008394827806

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10942056%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74170641&oldid=2186255957"